Nordic Nanovector to Present at 7th Annual Biotech Showcase Conference in San Francisco on 13 January 2015
Luigi Costa, CEO of Nordic Nanovector ASA, will provide a company presentation at the 7th Annual Biotech Showcase conference in San Francisco.
Nordic Nanovector will present as follows:
Date: Tuesday, 13 January 2015
Time: 11:30:00 AM PST
Track: B - Mission I (4th Floor)
Address: Parc 55 Wyndham San Francisco – Union Square
55 Cyril Magnin Street, 4th Floor
San Francisco, CA 94102
The slides from this presentation will be available on the “Report and Presentations” page in the Investor relation section of the company’s website at www.nordicnanovector.com after the conference.
Luigi Costa, CEO
Cell: (41) 79 124 8601
Fax: (47) 22 58 00 07
E-mail: lcosta@nordicnanovector.com
Tone Kvåle, CFO
Cell: (47) 91 51 95 76
Fax: (47) 22 58 00 07
E-mail: tkvale@nordicnanovector.com
About Nordic Nanovector ASA (ticker: NANO on NOTC)
Nordic Nanovector ASA is a privately held company established in 2009. The company is developing innovative radioimmunotherapeutics to treat non-Hodgkin Lymphoma (NHL) and other difficult to treat cancers. Nordic Nanovector intends to commercialise its product candidates through strategic alliances and partnerships with experienced oncology businesses and by establishing its own sales and marketing capabilities in selected markets. The company is based and has offices and laboratories in Oslo, Norway.
The company’s lead product candidate, Betalutin™, is a radioimmunotherapeutic that aims to prolong and improve the quality of life of people who suffer from NHL. Further information can be found at: www.nordicnanovector.com.
Tags:
